EVALUATION OF CHANGES IN CONTROL STATUS IN COPD: AN OPPORTUNITY FOR EARLY INTERVENTION: Control status is useful for clinical assessment.
Control has been proposed as a dynamic tool that can capture changes in the clinical status of patients with COPD. Prospective, multicenter, observational study aimed to compare changes in control over a 3-month period with changes in risk level, GOLD A-D categories and clinical phenotype (non-exacerbator, asthma-COPD overlap, exacerbator with emphysema or with chronic bronchitis). Control was defined as the presence of low clinical impact, assessed according to the degree of dyspnea, use of rescue medication, physical activity and sputum color, and clinical stability assessed by clinical changes and exacerbations in the last three months. Impact and stability were alternatively assessed with CAT scores. We included 354 patients, with a mean FEV1 of 49.8 (16.9)%. At 3 months, the proportion of controlled patients was 50.3% according to clinical evaluation and 47.8 according to CAT. Eighty-seven (29.2%) patients changed their control status as assessed by clinical variables and 85 (28.5%) according to CAT. In contrast, the risk level only changed in 26 (8.7%) patients (p<0.001), 27 (9.1%) experienced changes in their clinical phenotype (p<0.001) and 59 (19.8%) in the GOLD classification (p=0.008). Patients who showed an improvement in control status had better CAT scores at the end of follow-up (p<0.001). In only 3 months almost one third of patients experienced changes in their control status. Changes in control status were significantly more frequent than changes in phenotype, risk level and GOLD A-D categories, and resulted in significant changes in health status.